Abstract
The utilisation of antidiabetic drugs reflects both the prevalence of diabetes and the different therapeutic traditions of physicians. A questionnaire survey to study attitudes to the use of oral antidiabetic drugs amongst physicians and possible changes in treatment habits was carried out in a representative sample of Finnish physicians (n=454) in 1992 and the results were compared with those of a similar survey carried out in 1985, and with drug utilisation statistics.
The mean fasting blood glucose level at which a physician would start pharmacological treatment was 8.7 mmol·l−1, which was significantly lower than in the 1985 survey. The responses to various case histories suggested a more active approach to pharmacological treatment compared to the 1985 survey. Insulin treatment especially seems to have gained in popularity. This change in attitude was paralled by an increase in the consumption of antidiabetic drugs in Finland during the observation period. The increase in use of oral drugs was steeper in Finland than in Norway and Sweden.
Whether this active approach will improve the metabolic control and prognosis of patients with Type 2 diabetes, remains to be demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergman U (1979) International comparisons of drug utilization: use of antidiabetic drugs in seven European countries. In: WHO Regional Publications. European Series Copenhagen 8: 147–162
Groop P-H, Klaukka T, Reunanen A, Bergman U, Borch-Johnsen K, Damsgaard E-M, Hreidarsson AB, Midthjell K, St»lhammar J, Östman J (1991) Antidiabetic drugs in the Nordic countries. Reasons for variation in their use. (In Swedish with English summary). Publications of the Social Insurance Institution, Helsinki
Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and non-diabetic subjects. Diabetes Care 11: 449–463
Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyörälä K (1990) Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care 13: 41–48
WHO Drug Utilization Research Group (DURG) (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden.I. Diabetes. Eur J Clin Pharmacol 30: 513–519
Enlund H, Kähkönen H, Tuomilehto J, Uusitupa M (1988) Treatment practice of diabetes in East- and South-West-Finland (in Finnish). Suom Lääkäril (Finnish Medical J) 43: 468–473
Groop L, Nissen M, Salo S, Taskinen M-R, Uusitupa M (1989) Recommendations for the treatment of Type 2 diabetes mellitus (in Finnish). Publications of Finnish Diabetic Association. Tampere
Gries FA, Alberti KGMM (1987) Management of non-insulindependent diabetes mellitus in Europe: a consensus statement. IDF Bulletin 32: 169–174
The Finnish Committee on Drug Information and Statistics (1992). Finnish Statistics on Medicines 1991, National Agency for Welfare and Health and the Social Insurance Institution, Helsinki
Nordic Council on Medicines (1990) Nordic Statistics on Medicines 1987–1989. NLN Publication No 30, Uppsala
Laakso M, Reunanen A, Klaukka T, Aromaa A, Maatela J, Pyörälä K (1991) Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970–1987. Am J Epidemiol 133: 850–857
Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P, Tulokas T, Viikari J, Karjalainen J, Taskinen M-R (1992) Comparison of different insulin regimens in NIDDM. N Engl J Med 327: 1426–1433.
St»lhammar J, Bergman U, Boman K, Dahlen M (1991) Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs. Diabetes Care 14: 12–19
Uusitupa M, Laitinen J, Siitonen O, Vanninen E, Pyörälä K (1993) The maintenance of improved metabolic control after intensified diet therapy in recent Type 2 diabetes. Diabetes Res Clin Prac 19: 227–238
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niskanen, L., Enlund, H., Jormanainen, V. et al. Therapeutic traditions in type 2 diabetes — are they changing?. Eur J Clin Pharmacol 46, 101–105 (1994). https://doi.org/10.1007/BF00199870
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199870